The TREK2 Channel Is Involved in the Proliferation of 253J Cell, a Human Bladder Carcinoma Cell |
Park, Kyung-Sun
(Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology)
Han, Min Ho (Department of Biochemistry, Dongeui University College of Oriental Medicine) Jang, Hee Kyung (Department of Physiology, College of Medicine, Chungbuk National University) Kim, Kyung-A (Department of Biomedical Engineering, College of Medicine, Chungbuk National University) Cha, Eun-Jong (Department of Biomedical Engineering, College of Medicine, Chungbuk National University) Kim, Wun-Jae (Department of Urology, College of Medicine, Chungbuk National University) Choi, Yung Hyun (Department of Biochemistry, Dongeui University College of Oriental Medicine) Kim, Yangmi (Department of Physiology, College of Medicine, Chungbuk National University) |
1 | Pei L, Wiser O, Slavin A, Mu D, Powers S, Jan LY, Hoey T. Oncogenic potential of TASK3 (Kcnk9) depends on channel function. Proc Natl Acad Sci U S A. 2003;100:7803-7807. DOI ScienceOn |
2 | Han J, Gnatenco C, Sladek CD, Kim D. Background and tandem-pore potassium channels in magnocellular neurosecretory cells of the rat supraoptic nucleus. J Physiol. 2003;546: 625-639. DOI |
3 | Ghiani CA, Yuan X, Eisen AM, Knutson PL, DePinho RA, McBain CJ, Gallo V. Voltage-activated channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells. J Neurosci. 1999;19:5380-5392. |
4 | Woodfork KA, Wonderlin WF, Peterson VA, Strobl JS. Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture. J Cell Physiol. 1995;162:163-171. DOI ScienceOn |
5 | Ouadid-Ahidouch H, Roudbaraki M, Delcourt P, Ahidouch A, Joury N, Prevarskaya N. Functional and molecular identification of intermediate-conductance -activated channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol. 2004;287:C125-134. DOI ScienceOn |
6 | Smith GA, Tsui HW, Newell EW, Jiang X, Zhu XP, Tsui FW, Schlichter LC. Functional up-regulation of HERG channels in neoplastic hematopoietic cells. J Biol Chem. 2002;277:18528- 18534. DOI ScienceOn |
7 | Wonderlin WF, Woodfork KA, Strobl JS. Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J Cell Physiol. 1995;165:177-185. DOI ScienceOn |
8 | Ouadid-Ahidouch H, Le Bourhis X, Roudbaraki M, Toillon RA, Delcourt P, Prevarskaya N. Changes in the current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo channel. Receptors Channels. 2001;7:345-356. |
9 | Borowiec AS, Hague F, Gouilleux-Gruart V, Lassoued K, Ouadid-Ahidouch H. Regulation of IGF-1-dependent cyclin D1 and E expression by hEag1 channels in MCF-7 cells: the critical role of hEag1 channels in G1 phase progression. Biochim Biophys Acta. 2011;1813:723-730. DOI ScienceOn |
10 | Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003;36:131-149. DOI ScienceOn |
11 | Park KS, Kim Y. Functional expression of mechanosensitive two-pore domain potassium channel in human bladder carcinoma cells. J Biomed Res. 2013;14:71-76. DOI |
12 | Kang D, Kim D. TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background channels in dorsal root ganglion neurons. Am J Physiol Cell Physiol. 2006;291:C138-146. |
13 | Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, Robinson RB, Cordon-Cardo C, Feinmark SJ. TREK-1 is a novel molecular target in prostate cancer. Cancer Res. 2008;68:1197-1203. DOI ScienceOn |
14 | Kim Y, Kim WJ, Cha EJ. Quercetin-induced growth inhibition in human bladder cancer cells is associated with an increase in -activated channels. Korean J Physiol Pharmacol. 2011;15:279-283. DOI |
15 | Innamaa A, Jackson L, Asher V, van Schalkwyk G, Warren A, Keightley A, Hay D, Bali A, Sowter H, Khan R. Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer. Clin Transl Oncol. 2013;15:910-918. DOI |
16 | Kakehi Y, Hirao Y, Kim WJ, Ozono S, Masumori N, Miyanaga N, Nasu Y, Yokomizo A. Bladder Cancer Working Group report. Jpn J Clin Oncol. 2010;40 Suppl 1:i57-64. |
17 | Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27:289-293. DOI ScienceOn |
18 | Yamada T, Ueda T, Shibata Y, Ikegami Y, Saito M, Ishida Y, Ugawa S, Kohri K, Shimada S. TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer. Urology. 2010; 76:509 e501-507. |
19 | Li Q, Wang XH, Yang ZH, Wang HP, Yang ZW, Li SW, Zheng XM. [Induction of cell cycle arrest in bladder cancer RT4 cells by capsaicin]. Zhonghua Yi Xue Za Zhi. 2010;90:1230-1233. |
20 | Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100. DOI ScienceOn |
21 | Bang H, Kim Y, Kim D. TREK-2, a new member of the mechanosensitive tandem-pore channel family. J Biol Chem. 2000;275:17412-17419. DOI ScienceOn |
22 | Rouzaire-Dubois B, Dubois JM. channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation. J Physiol. 1998;510 (Pt 1):93-102. DOI ScienceOn |
23 | Wonderlin WF, Strobl JS. Potassium channels, proliferation and G1 progression. J Membr Biol. 1996;154:91-107. DOI ScienceOn |
24 | Es-Salah-Lamoureux Z, Steele DF, Fedida D. Research into the therapeutic roles of two-pore-domain potassium channels. Trends Pharmacol Sci. 2010;31:587-595. DOI ScienceOn |
25 | Kunzelmann K. Ion channels and cancer. J Membr Biol. 2005; 205:159-173. DOI ScienceOn |
26 | Ouadid-Ahidouch H, Ahidouch A. channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis. J Membr Biol. 2008;221:1-6. DOI ScienceOn |
27 | Li M, Xiong ZG. Ion channels as targets for cancer therapy. Int J Physiol Pathophysiol Pharmacol. 2011;3:156-166. |
28 | Kim KA, Kim Y. The effect of flavonoids on the TREK-1 channel. Journal of the Korea Academia-Industrial Cooperation Society. 2011;12:2660-2667. DOI ScienceOn |
29 | Becchetti A. Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. Am J Physiol Cell Physiol. 2011;301:C255-265. DOI ScienceOn |